SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Gold/Mining/Energy : Inflazyme Pharmaceuticals (T.IZP)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Harold Engstrom who wrote (788)1/21/1998 3:17:00 PM
From: Harold Lehman  Read Replies (2) of 1501
 
I've got to ask you, what was the method of delivery, besides inhalation, of Biogen's product?

Another question is what do you mean by an extremely effective suppression of the inflammatory response, quantitatively speaking, with that product? Also, what was the quantitative measure of inhibition of both the early stage and late phase of bronchoconstiction to an allergen with their product? Was it 90% or better in the sheep model as was Inflazyme's? I am asking for these details so we can all make a better evaluation of this particular competing product in development.

HL
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News